299 related articles for article (PubMed ID: 33787887)
1. Antibiotics and healthcare facility-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update.
Slimings C; Riley TV
J Antimicrob Chemother; 2021 Jun; 76(7):1676-1688. PubMed ID: 33787887
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
[No Abstract] [Full Text] [Related]
3. Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure.
Johnson SW; Brown SV; Priest DH
Clin Infect Dis; 2020 Aug; 71(5):1133-1139. PubMed ID: 31560051
[TBL] [Abstract][Full Text] [Related]
4. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis.
Slimings C; Riley TV
J Antimicrob Chemother; 2014 Apr; 69(4):881-91. PubMed ID: 24324224
[TBL] [Abstract][Full Text] [Related]
5. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset
Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M
Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129
[TBL] [Abstract][Full Text] [Related]
6. Healthcare facility-onset, healthcare facility-associated
Evans CT; Fitzpatrick M; Ramanathan S; Kralovic SM; Burns SP; Goldstein B; Smith B; Gerding DN; Johnson S
J Spinal Cord Med; 2020 Sep; 43(5):642-652. PubMed ID: 31663843
[No Abstract] [Full Text] [Related]
7. Antibiotic-Specific Risk for Community-Acquired
Zhang J; Chen L; Gomez-Simmonds A; Yin MT; Freedberg DE
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0112922. PubMed ID: 36377887
[TBL] [Abstract][Full Text] [Related]
8. Clostridioides difficile Infection in Children: The Role of Infection Prevention and Antimicrobial Stewardship.
Savage TJ; Sandora TJ
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S64-S68. PubMed ID: 34791402
[TBL] [Abstract][Full Text] [Related]
9. Incidence of and risk factors for recurrent Clostridioidesdifficile infection in Japan using a claims database: A retrospective cohort study.
Mikamo H; Kondo T; Okuyama K; Marcella SW; Ruzicka DJ
Anaerobe; 2020 Feb; 61():102139. PubMed ID: 31830597
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic exposure and the risk of hospital-acquired diarrhoea and Clostridioides difficile infection: a cohort study.
Schechner V; Fallach N; Braun T; Temkin E; Carmeli Y
J Antimicrob Chemother; 2021 Jul; 76(8):2182-2185. PubMed ID: 33969419
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis.
Sholeh M; Krutova M; Forouzesh M; Mironov S; Sadeghifard N; Molaeipour L; Maleki A; Kouhsari E
Antimicrob Resist Infect Control; 2020 Sep; 9(1):158. PubMed ID: 32977835
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales.
Tydeman F; Craine N; Kavanagh K; Adams H; Reynolds R; McClure V; Hughes H; Hickman M; Robertson C
J Antimicrob Chemother; 2021 Aug; 76(9):2437-2445. PubMed ID: 34151964
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
Wombwell E; Patterson ME; Bransteitter B; Gillen LR
Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for recurrent healthcare-facility associated Clostridioides difficile infection in a Swedish setting.
Karp J; Edman-Wallér J; Toepfer M; Jacobsson G
Anaerobe; 2023 Jun; 81():102738. PubMed ID: 37217115
[TBL] [Abstract][Full Text] [Related]
15. Differences in time-to-testing and time-to-isolation between community-onset and hospital-onset Clostridioides difficile cases at a tertiary care VA medical center.
Hostler CJ; Bertumen JB; Park LP; Wilkins SB; Woods CW
Am J Infect Control; 2020 Oct; 48(10):1148-1151. PubMed ID: 31911067
[TBL] [Abstract][Full Text] [Related]
16. Association between Antibiotic Consumption and Incidence of
Kim B; Kim J; Pai H
J Korean Med Sci; 2020 Dec; 35(47):e407. PubMed ID: 33289370
[TBL] [Abstract][Full Text] [Related]
17. Associations of facility-level antibiotic use and hospital-onset
Kazakova SV; Baggs J; Yi SH; Reddy SC; Hatfield KM; Guh AY; Jernigan JA; McDonald LC
Infect Control Hosp Epidemiol; 2022 Aug; 43(8):1067-1069. PubMed ID: 33958010
[TBL] [Abstract][Full Text] [Related]
18. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
Finn E; Andersson FL; Madin-Warburton M
BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
[TBL] [Abstract][Full Text] [Related]
19. Association Between Antibiotic Use and Hospital-onset Clostridioides difficile Infection in US Acute Care Hospitals, 2006-2012: An Ecologic Analysis.
Kazakova SV; Baggs J; McDonald LC; Yi SH; Hatfield KM; Guh A; Reddy SC; Jernigan JA
Clin Infect Dis; 2020 Jan; 70(1):11-18. PubMed ID: 30820545
[TBL] [Abstract][Full Text] [Related]
20. Increasing prevalence of the epidemic ribotype 106 in healthcare facility-associated and community-associated Clostridioides difficile infection.
Suárez-Bode L; Barrón R; Pérez JL; Mena A
Anaerobe; 2019 Feb; 55():124-129. PubMed ID: 30550807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
